Evidence map›Paper›PMID 37859735›Full record

ArticleTranslational cancer research2023

Severe COVID-19 outcomes and hematological cancers: the clot thickens-are platelets the culprit?

Lenard M Lichtenberger, K Vinod Vijayan

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational cancer research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Lenard M LichtenbergerDepartment of Integrative Biology & Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.
K Vinod VijayanDepartment of Medicine, Baylor College of Medicine and Center for Translational Research on Inflammatory Diseases, Michael E. DeBakey, Veterans Affairs Medical Center, Houston, TX, USA.

Funding

Aspirin-PC for Chemoprevention of Colorectal CancerR42CA171408 · NCI · PLX OPCO, INC. · PI LICHTENBERGER, LENARD M · 2017 to 2019
$2.0M
Platelet Serine/Threonine Phosphatases in Cancer PathophysiologyR01CA247917 · NCI · BAYLOR COLLEGE OF MEDICINE · PI VIJAYAN, K. VINOD · 2021 to 2025
$1.7M
NCI NIH HHS R01 CA247917NCI NIH HHS R42 CA171408
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anti-CD20 therapybreakthrough infectionsHematological cancerplateletsrituximab

Identifiers

PMID37859735
PMCPMC10583002

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.